Taro Pharmaceutical Industries (FRA:TAL) Gross-Profit-to-Asset % : 14.76% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Taro Pharmaceutical Industries Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Taro Pharmaceutical Industries's annualized Gross Profit for the quarter that ended in Dec. 2023 was €293.0 Mil. Taro Pharmaceutical Industries's average Total Assets over the quarter that ended in Dec. 2023 was €1,984.8 Mil. Therefore, Taro Pharmaceutical Industries's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 14.76%.

Taro Pharmaceutical Industries Gross-Profit-to-Asset % Historical Data

The historical data trend for Taro Pharmaceutical Industries's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taro Pharmaceutical Industries Gross-Profit-to-Asset % Chart

Taro Pharmaceutical Industries Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

20.42

18.05

12.04

13.31

12.62

Taro Pharmaceutical Industries Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															11.36	14.18	11.93	13.94	14.76

Competitive Comparison of Taro Pharmaceutical Industries's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Taro Pharmaceutical Industries's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Taro Pharmaceutical Industries's Gross-Profit-to-Asset % falls into.

Taro Pharmaceutical Industries Gross-Profit-to-Asset % Calculation

Taro Pharmaceutical Industries's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Mar. 2023 )	/	( (Total Assets (A: Mar. 2022 )	+	Total Assets (A: Mar. 2023 ))	/ count )
	=	250.614	/	( (1976.137	+	1994.569)	/ 2 )
	=	250.614	/	1985.353
	=	12.62 %

Taro Pharmaceutical Industries's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	293.004	/	( (1985.946	+	1983.635)	/ 2 )
	=	293.004	/	1984.7905
	=	14.76 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Taro Pharmaceutical Industries Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Taro Pharmaceutical Industries (FRA:TAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taro Pharmaceutical Industries Ltd (FRA:TAL) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

TARO:USA

Address

14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761

Website

https://www.taro.com

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.